Overview
The US Agency for Toxic Substances and Disease Registry derived oral Minimal Risk Levels for aluminum in its September 2008 Toxicological Profile, anchored on neurotoxic effects in lifetime-exposed mice (Golub et al. 2000) (ATSDR 2008). The chronic-duration oral MRL is 1 mg aluminum (Al)/kg/day, the same value as the intermediate-duration oral MRL (ATSDR 2008). An acute-duration oral MRL was not derived because the available data were considered inadequate (ATSDR 2008).
Minimal Risk Levels
| Route | Duration | MRL |
|---|---|---|
| Oral | Acute (≤14 days) | Not derived (inadequate data) |
| Oral | Intermediate (15-364 days) | 1 mg Al/kg/day |
| Oral | Chronic (≥1 year) | 1 mg Al/kg/day |
For a 70-kilogram adult, the chronic oral MRL corresponds to 70 mg Al/day (ATSDR 2008).
Critical endpoint and derivation
| Parameter | Value |
|---|---|
| Critical study | Golub et al. 2000 |
| Critical effect | Decreased forelimb and hindlimb grip strength, decreased thermal sensitivity in lifetime-exposed mice |
| LOAEL | 100 mg Al/kg/day |
| Composite uncertainty factor | 100 (10 for animal-to-human extrapolation × 10 for human variability) |
| Chronic oral MRL | 100 ÷ 100 = 1 mg Al/kg/day |
Relationship to EFSA TWI
The ATSDR chronic oral MRL of 1 mg Al/kg/day is approximately 7-fold higher than the EFSA AFC TWI daily-equivalent of approximately 0.14 mg Al/kg/day (1 mg/kg/week ÷ 7). The discrepancy is methodological: ATSDR’s derivation uses the LOAEL-with-uncertainty-factor pathway from a single critical study (Golub et al. 2000); the EFSA AFC Panel 2008 integrates evidence across multiple animal endpoints with a different safety-factor structure. HMT&C calibration to the EFSA TWI is the more conservative posture; calibration to the ATSDR MRL is the more permissive.
Aluminum bioavailability context
The 2008 profile (ATSDR 2008) records aluminum gastrointestinal bioavailability ranges that constrain dose-translation:
| Source | Bioavailability |
|---|---|
| Drinking water | 0.07 to 0.39 percent |
| Diet (typical aluminum compounds) | 0.1 percent |
| Aluminum lactate (specific compound) | Higher than typical dietary forms; suggests compound-specific variation |
Typical adult dietary aluminum intake of 5 to 15 mg/day is well below the chronic oral MRL of 70 mg/day for a 70 kg adult (ATSDR 2008). Aluminum-containing antacid use (typical user: 100 to 1000 mg/day delivered) substantially exceeds the MRL on a body-weight-normalized basis (ATSDR 2008).
Sources
- ATSDR 2008 — ATSDR, September 2008. Toxicological Profile for Aluminum.
References
Works cited in this page’s text, in first-appearance order. See Sources for this page’s source inventory. Each title links to a source record with bibliographic details, reported findings, and document provenance.
- Toxicological Profile for AluminumGovernment
- Safety of Aluminium from Dietary IntakeGovernment
Update history
No substantive edit history is available in this build. The full commit record is available in git.
